Literature DB >> 14513371

Colour junctions as predictors of radiosensitivity: X-irradiation combined with gemcitabine in a lung carcinoma cell line.

Natasja Castro Kreder1, Chris Van Bree, Nicolaas A P Franken, Jaap Haveman.   

Abstract

PURPOSE: To determine whether measurement of colour junctions by fluorescent in situ hybridisation (FISH) can predict radiosensitisation of gemcitabine (2'-2'-difluorodeoxycytidine).
METHODS: Human lung carcinoma cells (SW-1573) were irradiated with X-rays with or without incubation of 10 n M gemcitabine for 24 h. Cell survival was determined with clonogenic assay. Colour junctions were measured by whole chromosome FISH of chromosomes 2 and 18 and were scored according to the PAINT method.
RESULTS: A clear radiosensitisation by gemcitabine was observed on cell survival. A significant decrease in the number of colour junctions was observed after gemcitabine treatment compared with radiation treatment alone. The correlation between colour junction induction and cell survival was high for both with and without gemcitabine, but the gemcitabine-sensitised curve did not coincide with the non-sensitised curve.
CONCLUSIONS: Gemcitabine-induced radiosensitisation is not predicted by induction of colour junctions in cultured SW-1573 cells. This reduces the clinical applicability of this predictive assay for radiotherapy in combination with gemcitabine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14513371     DOI: 10.1007/s00432-003-0479-x

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  30 in total

1.  Frequencies of X-ray-induced chromosome translocations in human peripheral lymphocytes as detected by in situ hybridization using chromosome-specific DNA libraries.

Authors:  A T Natarajan; R C Vyas; F Darroudi; S Vermeulen
Journal:  Int J Radiat Biol       Date:  1992-02       Impact factor: 2.694

2.  Phase I study of twice-weekly gemcitabine and concurrent thoracic radiation for patients with locally advanced non-small-cell lung cancer.

Authors:  A W Blackstock; G J Lesser; J Fletcher-Steede; L D Case; R W Tucker; S M Russo; D R White; A Miller
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-12-01       Impact factor: 7.038

3.  Potential of radiation-induced chromosome aberrations to predict radiosensitivity in human tumour cells.

Authors:  J M Coco Martin; E Mooren; C Ottenheim; W Burrill; M I Nunez; D Sprong; H Bartelink; A C Begg
Journal:  Int J Radiat Biol       Date:  1999-09       Impact factor: 2.694

4.  The effect of 2'-2' difluorodeoxycytidine (dFdC, gemcitabine) on radiation-induced cell lethality in two human head and neck squamous carcinoma cell lines differing in intrinsic radiosensitivity.

Authors:  J F Rosier; M Beauduin; M Bruniaux; M de Bast; B de Coster; M Octave-Prignot; P Scalliet; V Grégoire
Journal:  Int J Radiat Biol       Date:  1999-02       Impact factor: 2.694

5.  Significant increase in residual DNA damage as a possible mechanism of radiosensitization by gemcitabine.

Authors:  Christian Weiss; Gerhard G Grabenbauer; Rolf Sauer; Luitpold Distel
Journal:  Strahlenther Onkol       Date:  2003-02       Impact factor: 3.621

6.  Radiosensitizing potential of gemcitabine (2',2'-difluoro-2'-deoxycytidine) within the cell cycle in vitro.

Authors:  D Latz; K Fleckenstein; M Eble; J Blatter; M Wannenmacher; K J Weber
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-07-01       Impact factor: 7.038

7.  Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine.

Authors:  T S Lawrence; E Y Chang; T M Hahn; L W Hertel; D S Shewach
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-03-01       Impact factor: 7.038

8.  Use of fluorescence in situ hybridization to determine the relationship between chromosome aberrations and cell survival in eight human fibroblast strains.

Authors:  N S Russell; C F Arlett; H Bartelink; A C Begg
Journal:  Int J Radiat Biol       Date:  1995-08       Impact factor: 2.694

9.  Effect of 2',2'-difluorodeoxycytidine on the viability and radiosensitivity of EMT6 cells in vitro.

Authors:  S Rockwell; G B Grindey
Journal:  Oncol Res       Date:  1992       Impact factor: 5.574

10.  Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines.

Authors:  Chris van Bree; Natasja Castro Kreder; Willem J P Loves; Nicolaas A P Franken; Godefridus J Peters; Jaap Haveman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-09-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.